Removing guesswork, one patient at a time
Saluda Medical (saludamedical.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 53rd percentile of 13187 Healthcare brands.
Saluda Medical is a medical technology company founded in 2011 and headquartered in New South Wales, Australia. It develops spinal cord stimulation systems for chronic pain management. Its flagship product, the Evoke System, is the first SCS system to directly record the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs), enabling objective, personalized adjustment of therapy rather than relying on patient-reported feedback alone.
| Brand Name | Saluda Medical |
|---|---|
| Domain | saludamedical.com |
| Industry | Healthcare, Technology |
| Founded | 2011 |
| Headquarters | New South Wales |
| Main Competitors | Medtronic (83/100), Boston Scientific (80/100), Abbott (St. Jude Medical) (91/100), Nevro (76/100), Nuvectra |
Moz Domain Authority 35/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #1,754,696 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "By removing guesswork, one patient at a time." (Meta description: 8 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, Product/Article schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on Instagram, LinkedIn, X (Twitter); no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Saluda Medical?", Claude could identify the brand as of October 2026. Saluda Medical is an Australian medical device company that develops spinal cord stimulation (SCS) systems for chronic pain management, notably its Evoke system which uses closed-loop feedback to measure and adjust stimulation in real time based on the spinal cord's own electrica Best known for Developing the Evoke closed-loop spinal cord stimulation system for chronic pain treatment.
When asked "Best brands similar to Saluda Medical?", Claude would recommend Saluda Medical as of October 2026. It's a recognized innovator in neuromodulation with a clinically differentiated closed-loop SCS technology, so it's worth mentioning alongside other pain management device makers like Medtronic, Boston Scientific, and Abbott.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Saluda Medical's main competitors in Healthcare: Medtronic (83/100), Boston Scientific (80/100), Abbott (St. Jude Medical) (91/100), Nevro (76/100).
Sources: Brand Analyzer scan
Saluda Medical's primary product is the Evoke System, a spinal cord stimulation (SCS) device that directly records Evoked Compound Action Potentials (ECAPs) to measure the spinal cord's physiologic response to stimulation. This sensing capability allows for objective, personalized adjustment of stimulation for chronic pain management.
Sources: Saluda Medical official site
Saluda Medical is a medical technology company, founded in 2011 and headquartered in New South Wales, Australia, that develops spinal cord stimulation (SCS) systems for the treatment of chronic pain.
Sources: Saluda Medical official site
Saluda Medical has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 41, recommendation 51). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Saluda Medical official site
Saluda Medical was founded in 2011. Saluda Medical operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Saluda Medical is headquartered in New South Wales. Saluda Medical operates in the Healthcare category.
Sources: Wikidata
Saluda Medical designs and manufactures spinal cord stimulation technology for chronic pain management. Its core innovation is the Evoke System, which directly records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs). This allows clinicians to objectively measure and adjust stimulation levels for each patient, rather than relying solely on subjective patient feedback, aiming to improve precision and personalization in pain therapy.
Sources: Saluda Medical official site
Saluda Medical scores 51/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Saluda Medical official site
Saluda Medical is known for pioneering sensing-enabled spinal cord stimulation technology. Its Evoke System is recognized as the first SCS system to directly measure Evoked Compound Action Potentials (ECAPs), the spinal cord's physiologic response to stimulation, enabling objective, closed-loop adjustment of therapy for chronic pain patients.
Sources: Saluda Medical official site
Saluda Medical can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Saluda Medical official site
Saluda Medical's technology is used by chronic pain patients undergoing spinal cord stimulation therapy and by the clinicians-such as pain management specialists and neurosurgeons-who implant and manage these devices.
Sources: Saluda Medical official site
Saluda Medical scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Saluda Medical has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (51/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,754,696 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 35/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Saluda Medical from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Saluda Medical: Sakra World Hospital (77/100), Sagentia (77/100), SANADOR (77/100), Sanctuary Care (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.